Huntington's disease (HD) is an autosomal dominant neurodegenerative disease linked to a polyQ (polyglutamine) expansion in the huntingtin protein. Although general brain atrophy is found in HD patients, the striatum is the most severely affected region. Loss or mutant forms of huntingtin were reported to disrupt fast axonal transport in Drosophila, squid, and mice. However, previous work did not resolve whether mutant huntingtin affects global axonal transport or only a subset of cargoes, nor did it resolve whether striatal neurons are preferentially sensitive to huntingtin-mediated defects. We used amyloid precursor protein (APP)-yellow fluorescent protein and brain-derived neurotrophic factor (BDNF)-mCherry fusion proteins as markers for fast axonal transport when huntingtin is altered. We found that movement of APP and BDNF is impaired in striatal and hippocampal, but not cortical, neurons from presymptomatic homozygous mutant mice carrying 150Q huntingtin knock-in mutations. In addition, loss of huntingtin disrupts APP axonal transport, whereas overexpression of wild-type, but not mutant, huntingtin enhances APP transport in all three types of neurons tested. These data suggest that a loss of wild-type huntingtin function in fast axonal transport plays important roles in the development of cell-type-specific defects in HD.
Introduction
In the nervous system, neurons interact with each other via long axonal and dendritic processes. In axons, macromolecules synthesized in the cell body are transported to synapses by motor proteins, such as kinesin and dynein , which move needed materials along microtubules. Defects in axonal transport can lead to neurodegenerative pathology and neurodegenerative diseases, such as Charcot-Marie-Tooth disease and hereditary spastic paraplegia SPG10 (Duncan and Goldstein, 2006 ). Huntington's disease (HD) is a hereditary dominant neurodegenerative disorder characterized by severe motor and memory dysfunction (Folstein, 1989; Harper, 1996; Ross and Margolis, 2001) . Evidence that axonal transport abnormalities might contribute to development of HD comes from examinations of postmortem HD patient brains, which revealed the existence of dystrophic neurites, a possible indication of axonal transport dysfunction (Jackson et al., 1995; DiFiglia et al., 1997; Sapp et al., 1999) .
HD is linked genetically to expansion of a polyglutamine (polyQ) repeat within the N terminus of the huntingtin protein (The Huntington's Disease Collaborative Research Group, 1993) . Huntingtin associates with microtubules and various vesicles including mitochondria and synaptic vesicles (DiFiglia et al., 1995; Bhide et al., 1996; Velier et al., 1998; Li et al., 2003) . Both huntingtin and the huntingtin-associated protein 1 (HAP1) move in axons in both anterograde and retrograde directions (Block-Galarza et al., 1997) and have been reported to associate with both the anterograde and retrograde transport machinery (Engelender et al., 1997; Li et al., 1998; McGuire et al., 2006; Caviston et al., 2007) . Several studies suggest that wild-type huntingtin plays roles in axonal transport and that mutant huntingtin interferes with these processes, which may cause neuronal dysfunction and eventually neuronal death (Gunawardena et al., 2003; Szebenyi et al., 2003; Gauthier et al., 2004; Lee et al., 2004; Trushina et al., 2004; Chang et al., 2006; Orr et al., 2008) . However, it is controversial whether mutant huntingtin affects axonal transport of all or only a subset of cargoes and whether mutant huntingtin affects axonal transport in all or only certain types of neurons. Thus, we compared directly the effects of loss or polyQ mutation of huntingtin on axonal transport of brain-derived neurotrophic factor (BDNF) and amyloid precursor protein (APP), a cargo of kinesin and dynein (Kamal et al., 2000; Stokin et al., 2005) , in primary cortical, striatal, and hippocampal neurons.
Materials and Methods

Mice and genetic crosses. Hdh
Flox mice (Dragatsis et al., 2000) and Hdh150Q mice (Lin et al., 2001) were both maintained in a C57BL/6J background according to the Guide for the Care and Use of Laboratory Animals. For endogenous huntingtin depletion experiments, female homozygous Hdh Flox mice were crossed with male homozygous Hdh Flox mice to produce homozygous Hdh Flox mice for primary cortical neuron culture. For experiments comparing the effect of endogenous mutant huntingtin on axonal transport, female heterozygous Hdh150Q mice were crossed with male heterozygous Hdh150Q mice to generate either wild-type Hdh or homozygous Hdh150Q littermates for primary neuron cultures. All animal procedures were reviewed and approved by the University of California, San Diego Institutional Animal Care and Use Committee.
Cell cultures. Primary cortical, striatal, and hippocampal cells were prepared from postnatal day 1 mice and cultured as described previously with minor modifications (Brewer, 1995 (Brewer, , 1997 . Neocortex, striatum, and hippocampi were excised in cold HBSS (Invitrogen). For cortical and striatal neuron preparation, neocortex and striatum were digested with a Papain Dissociation kit (Worthington Biochemicals) for 30 min at 37°C. For hippocampal neuron preparation, hippocampi were digested with a 0.22 m-filtered mixture of 45U papain (Worthington Biochemicals) in PBS (Invitrogen), DL-cysteine HCl (Sigma), bovine serum albumin (Sigma), and D-glucose (Sigma) with 0.05% DNase (Roche Diagnostics) for 30 min at 37°C. After papain digestion, neocortex, striatum, and hippocampi were triturated 20 times in 2 ml of growth medium and plated at 100,000 cells per well of a 24-well dish coated with poly-L-lysine and laminin (Sigma). Cortical and hippocampal neurons were maintained in 0.5 mM glutamine and B27 (Invitrogen) supplemented with Neurobasal medium (Invitrogen) at 37°C in 5% CO 2 . Striatal neurons were maintained in 1 mM glutamine and B27 (Invitrogen) supplemented with Neurobasal medium at 37°C in 5% CO 2 .
Transfection. Primary cortical, striatal, and hippocampal neurons were transfected with Lipofectamine 2000 as recommended (Invitrogen) on 4, 9, and 12 d in vitro (DIV), respectively. The constructions of pCMV-APPYFP, pEBV-HTTQ23F, and pEBV-HTTQ120F plasmids were described previously (Kaether et al., 2000; Zhou et al., 2003) . The pCAG-APPYFP and pJPA5-BDNF-mCherry plasmids were gifts from Dr. Z. Yang (University of California, San Diego, San Diego, CA) and Dr. G. Banker (Oregon Health & Sciences University, Portland, OR), respectively.
In vivo imaging. In vivo movements of APP-yellow fluorescent protein (YFP) and BDNF-mCherry were imaged in primary cultures at 37°C in 5% CO 2 on a heating stage (Harvard Apparatus) with an inverted epifluorescent microscope (TE-2000U; Nikon) connected to a Photometrics CoolSNAPHQ-cooled CCD camera (Roper Scientific). Images were captured at a speed of 10 frames per second for 15 s for each stream acquisition stack at 100ϫ magnification and 2 ϫ 2 binning by MetaMorph 6.0 (Universal Imaging Corporation). Image stacks were converted to kymographs and analyzed by MetaMorph (Universal Imaging Corporation). For APP-YFP and BDNF-mCherry movement, images were recorded 16 and 5 h after transfection, respectively. Each experiment was performed twice.
Statistical analysis. Kymographs of APP-YFP and BDNF-mCherry movements were analyzed manually as described previously (Stokin et al., 2005) . Comparisons of average velocity and particle distributions were done using unpaired two-tailed t tests. The data are presented as mean Ϯ SE. Differences between samples were considered significant when p Ͻ 0.05 and very significant when p Ͻ 0.01.
Tat-cre purification and treatment and viability assay. Recombinant tat-cre protein was expressed and purified as described previously (Wadia et al., 2004) . In brief, the pTat-cre plasmid was transformed into BL21 cells (Novagen). Exponentially growing cells from cultures diluted overnight were induced with 500 M isopropyl ␤-D-thiogalactoside for 5 h. Recombinant tat-cre protein was purified by successive steps of the Ni-NTA column (Qiagen) and Source 30S column (Pfizer). Aliquots of purified tat-cre were stored at Ϫ70°C in 10% glycerol. For treatment, primary cortical neurons were incubated with 500 l of 1 mM tat-cre and 5 M recombinant tat-HA2 peptide in Neurobasal medium for the times stated. After incubation, cells were washed with Neurobasal medium to remove unbound tat-cre. Forty-eight hours after tat-cre treatment, cortical neurons were washed with phosphate-based buffer (PBS) and stained with 15 g/ml fluorescein diacetate (FDA) and 4.6 g/ml propidium iodide (PI) in PBS for 15 min at room temperature. After excitation, live cells emit green fluorescence, and dead cells display red fluorescence (Brewer et al., 1993) . As a control for dead cells, cortical neurons were treated with 50% methanol in PBS for 10 min at room temperature before the viability test.
Western blot. Soluble protein extracts were prepared as described previously (Gunawardena et al., 2003) . In brief, brains were dounce homogenized in buffer A (in mM: 250 sucrose, 15 Tris-HCl, pH 7.9, 60 KCl, 15 NaCl, 5 EDTA, 1 EGTA, 0.5 DTT) and protease inhibitors (Roche). The lysate was centrifuged at 4000 ϫ g for 10 min, and the supernatant was collected and centrifuged again at 18,000 ϫ g for 10 min. the second supernatant was collected and stored at Ϫ20°C for Western blots. The protein concentrations were measured by the DC Protein Assay (BioRad). Equal amounts of protein lysates were loaded on 4 -12% Bis-Tris NuPage gels (Invitrogen). After electrophoresis, the samples were transferred to nitrocellulose membrane (Bio-Rad) at 100 mA for 15 h at 4°C (25 mM 190 mM glycine, and 20% methanol) . After transfer, the membranes were blocked with 5% nonfat milk in TBS-T buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, and 0.05% Tween 20) after being washed briefly with TBS-T buffer. The membranes were then incubated with a primary antibody at 4°C overnight. After washing membranes with TBS-T buffer three times with 5 min intervals, membranes were incubated with a corresponding HRP-coupled or fluorescence-coupled secondary antibody at room temperature for 60 min. After washing four times with TBS-T buffer at 5 min intervals, membranes were developed with enhanced chemiluminescence or the Odyssey system as described (GE Healthcare and Li-Cor). Quantization of intensity was done using Odyssey 2.1 software (Li-Cor) .
Antibodies. We used anti-huntingtin (HTT) (MAB2166, 1:1000; Millipore Bioscience Research Reagents), anti-kinesin heavy chain (KHC; MAB1614, 1:1000; Millipore Bioscience Research Reagents), anti-dynein heavy chain (DHC; SC-9115, 1:500; Santa Cruz Biotechnology), anti-BDNF (SC-546, 1:500; Santa Cruz Biotechnology), anti-DARPP32 (AB1656, 1:500; Millipore Bioscience Research Reagents), anti-GAD67 (MAB5406, 1:1000; Millipore Bioscience Research Reagents), anti-APP (MAB348, 1:1000; Millipore Bioscience Research Reagents), antip150Glued (671208, 1:250; BD Biosciences), anti-HAP1 (611302, 1:250; BD Biosciences), anti-p50 (611003, 1:250; BD Biosciences), anti-␣-tubulin (1:5000; Sigma), and anti-actin (Roche Diagnostics).
Sucrose gradient fractionation. Sucrose gradient experiments were performed as described previously (LaMonte et al., 2002) . In brief, brain extracts were prepared by dounce homogenization in buffer A (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, and 1 mM EDTA) plus protease inhibitors (Roche). The crude extracts were centrifuged at 10,000 ϫ g for 10 min at 4°C. Approximately 100 l of supernatants (20 mg/ml) was overlaid on a 10.3 ml, 5-20% sucrose gradient and centrifuged at 32,000 ϫ g for 16 h at 4°C in an SW40 rotor (Beckman Coulter). After centrifugation, 800 l fractions were collected from the top and analyzed by Western blot assays.
Results
Depletion of huntingtin in primary mouse cortical neurons disrupts axonal transport of APP Previous reports had shown that reduction of endogenous huntingtin in retinoblastoma cells and striatal neurons impairs axonal transport (Gauthier et al., 2004; Trushina et al., 2004 ). Here we tested whether depletion of endogenous huntingtin also disrupts axonal transport in primary cortical neurons. To completely remove expression of endogenous mouse huntingtin in primary neurons, we used the cre-loxP system. In Hdh floxed mice, exon 1 of the Hdh gene is flanked by two loxP sequences (Dragatsis et al., 2000) . In the presence of cre protein, exon 1 of the Hdh gene is removed by recombination of the two loxP sites, thereby completely abolishing the expression of huntingtin. To introduce cre protein, primary cortical neurons (3 or 4 DIV) cultured from homozygous Hdh floxed mice were incubated with recombinant tat-cre protein, a fusion protein between cre and the protein transduction domain of human immunodeficiency virus tat protein that allows proteins to enter cells efficiently (Wadia et al., 2004) . After a 60 min treatment with the tat-cre protein, cells were incubated for 48 h, at which time total protein samples were prepared and subjected to Western blot analysis. We found that recombinant tat-cre protein efficiently reduced the level of endogenous huntingtin protein such that Ͻ25% of normal levels of huntingtin remained at the time examined (Fig. 1 A) . Depletion of huntingtin in primary cortical neurons did not affect the level of motor proteins such as KHC and DHC (Fig. 1 A) .
Because complete loss of huntingtin results in embryonic lethal phenotypes in mice (Duyao et al., 1995; Nasir et al., 1995; Zeitlin et al., 1995) , we tested whether depletion of huntingtin causes neuronal death. Forty-eight hours after tat-cre treatment, cortical neurons were stained with FDA and PI. After excitation, live cells emit green fluorescence, and dead cells display red fluorescence ( Fig. 1 B, middle panel). We found that depletion of huntingtin does not affect viability of cortical neurons at the 48 h time point because there are no red PI-positive neurons ( Fig. 1 B, top and bottom panels).
To evaluate the role of huntingtin in axonal transport, we monitored the kinesin-and dynein-dependent movement of AP-P-YFP in huntingtin-depleted primary cortical neurons. To differentiate axons from dendrites while imaging, we used the morphology of projections as a guide. In general, axons are long, whereas dendrites are shorter with multiple branches. To confirm these criteria, primary cortical neurons (4 DIV) were transfected with EB3-mCherry, a neuronal microtubule plus-end binding protein (Stepanova et al., 2003) . We found that the movement of EB3-mCherry in long projections is uniformly outward (data not shown), a characteristic of axons. Thus, we recorded and analyzed APP-YFP movement in long projections. A total of 304 APP-YFP particles from 23 control cells and 353 APP-YFP particles from 33 tat-cre-treated cells were assessed. As shown ( disrupts both directions of axonal APP movement in cultured primary cortical neurons.
Overexpression of full-length wild-type huntingtin enhances axonal transport of APP in primary cortical, striatal, and hippocampal neurons Overexpression of full-length wild-type huntingtin increases transport of BDNF both in the NG108-15 retinoblastoma cells and primary cortical neurons (Gauthier et al., 2004) . To test whether wild-type huntingtin enhances axonal transport of cargoes other than BDNF and whether the effect of huntingtin overexpression on axonal transport is limited to certain types of neurons, we monitored APP-YFP transport in cultured primary mouse cortical, striatal, and hippocampal neurons. To verify the cell-type composition of isolated cortical and striatal neurons, total proteins from cultured primary neurons were analyzed by Western blot assays. Consistent with previous reports (Altar et al., 1997) , only cortical but not striatal neurons expressed BDNF (Fig. 2 A) . In contrast, striatal neurons expressed high levels of DARPP32 and GAD67 ( Fig. 2 A) , two proteins that are highly expressed in striatal medium spiny neurons (MSNs) (Reiner et al., 1998) . Thus, isolated cortical and striatal neurons express proteins characteristic of each type of neuron. To examine the effects of wild-type huntingtin overexpression on APP axonal transport, primary neurons were cotransfected with plasmids encoding APP-YFP and full-length wild-type human huntingtin.
To estimate the level of huntingtin in transfected neurons, total proteins from cortical and striatal neurons were prepared 24 h after transfection and subjected to Western blot assays. The level of total huntingtin is ϳ30% higher in cultured neurons cotrans- fected with APP-YFP and wild-type huntingtin compared with APP-YFP alone ( Fig. 2 B, compare middle, left panels). Because the transfection efficiency is ϳ2-5% of total cells (measured by counting APP-YFP-positive neurons; data not shown), these data suggest that the level of huntingtin is ϳ13-to 33-fold higher than endogenous mouse huntingtin in transfected cortical neurons. In transfected striatal neurons, the level of total huntingtin is ϳ50% higher in cells cotransfected with APP-YFP and wild-type huntingtin compared with APP-YFP alone (Fig. 2C , compare middle, left panels), suggesting that the expression level of huntingtin is ϳ10-to 25-fold higher than endogenous mouse huntingtin in transfected striatal neurons.
To examine the effects of wild-type huntingtin overexpression on APP transport in primary cortical neurons, APP-YFP movement was recorded and analyzed as described previously. A total of 293 APP-YFP particles from 18 cells transfected with APP-YFP alone and 314 APP-YFP particles from 24 cells cotransfected with wild-type huntingtin were analyzed. Overexpression of full-length wild-type huntingtin increases the speed of both anterograde (0.86 vs 1.33 m/s; p Ͻ 0.0001) and retrograde (0.69 vs 1.01 m/s; p ϭ 0.0003) APP-YFP movements in cortical neurons (Fig. 3A) . Overexpression of wild-type huntingtin does not change the number of stationary APP-YFP particles in cortical neurons (Fig. 3B) .
In primary striatal neurons, a total of 226 APP-YFP particles from nine cells transfected with APP-YFP alone and 234 APP-YFP particles from 16 cells cotransfected with wild-type huntingtin were evaluated. We found that overexpression of full-length wild-type huntingtin increases the speed of both anterograde (0.72 vs 0.99 m/s; p Ͻ 0.001) and retrograde (0.47 vs 0.82 m/s; p ϭ 0.003) APP-YFP movements in striatal neurons (Fig. 3C) . Overexpression of wild-type huntingtin does not change the number of stationary APP-YFP particles in striatal neurons (Fig. 3D) .
In primary mouse hippocampal neurons, a total of 372 APP-YFP particles from 11 cells transfected with APP-YFP alone and 185 APP-YFP particles from 10 cells cotransfected with wild-type huntingtin were analyzed. We found that overexpression of wildtype huntingtin increases the velocity of both anterograde (0.65 vs 0.85 m/s; p Ͻ 0.001) and retrograde (0.37 vs 0.8 m/s; p Ͻ 0.05) movement of APP-YFP (Fig. 3E) . Overexpression of wildtype huntingtin does not change the number of stationary APP-YFP particles in hippocampal neurons (Fig. 3F ) .
Thus, overexpression of wild-type huntingtin accelerates anterograde and retrograde APP axonal transport in both cortical, striatal, and hippocampal neurons.
Overexpression of full-length mutant huntingtin increases the number of stationary APP-YFP particles in primary striatal and hippocampal but not cortical neurons Because overexpression of wild-type huntingtin accelerates axonal transport of APP in cultured primary cortical and striatal neurons, we asked whether overexpression of mutant huntingtin has comparable effects. After transfection, to estimate the level of mutant huntingtin in transfected neurons, total proteins were prepared 24 h after transfection and subjected to Western blot assays. In transfected cortical neurons, the level of total huntingtin is ϳ40% higher in cells cotransfected with mutant huntingtin (Fig. 2 B, compare left, right panels) . Taking into consideration that the transfection efficiency is ϳ2-5%, the expression level of transfected mutant huntingtin is ϳ8-to 20-fold higher than endogenous wild-type huntingtin in cortical neurons. In striatal neurons, the level of huntingtin is ϳ88% higher in cells cotransfected with mutant huntingtin (Fig. 2C , compare left, right panels), suggesting that the level of transfected mutant huntingtin is ϳ18-to 40-fold higher than endogenous wild-type huntingtin in striatal neurons.
In primary cortical neurons, a total of 293 APP-YFP particles from 18 cells transfected with APP-YFP alone and 286 APP-YFP particles from 18 cells cotransfected with mutant huntingtin were analyzed. We found that overexpression of full-length mutant huntingtin does not significantly change the velocity of either anterograde (0.86 vs 0.67 m/s; p Ͼ 0.05) or retrograde (0.69 vs 0.53 m/s; p Ͼ 0.05) APP-YFP movements in cortical neurons (Fig. 4 A) . Overexpression of full-length mutant huntingtin does not change the number of stationary APP-YFP particles in cortical neurons (Fig. 4 B) .
In primary striatal neurons, a total of 226 APP-YFP particles from 9 cells transfected with APP-YFP alone and 272 APP-YFP particles from 11 cells cotransfected with mutant huntingtin were evaluated. Similar to cortical neurons, overexpression of full-length mutant huntingtin does not significantly change the speed of either anterograde (0.73 vs 0.74 m/s; p Ͼ 0.05) or retrograde (0.47 vs 0.52 m/s; p Ͼ 0.05) APP-YFP movements in striatal neurons (Fig. 4C) . However, overexpression of mutant huntingtin increases the number of stationary APP-YFP particles in striatal neurons (Fig. 4 D) .
In primary mouse hippocampal neurons, a total of 372 APP-YFP particles from 11 cells transfected with APP-YFP alone (controls from previous section) and 392 APP-YFP particles from 14 cells cotransfected with mutant huntingtin were evaluated. Similar to cortical and striatal neurons, overexpression of mutant full-length huntingtin does not significantly change the speed of either anterograde (0.65 vs 0.48 m/s; p Ͼ 0.05) or retrograde (0.37 vs 0.26 m/s; p Ͼ 0.05) APP-YFP movements in hippocampal neurons (Fig. 4 E) . Similar to the observation in striatal neurons, overexpression of mutant huntingtin increased the number of stationary APP-YFP particles in hippocampal neurons (Fig. 4 F) .
Thus, overexpression of mutant huntingtin does not affect the velocity of APP-YFP movement significantly in cortical, striatal, or hippocampal neurons. Interestingly, overexpression of mutant full-length huntingtin does increase the number of stationary APP-YFP particles in striatal and hippocampal, but not cortical, neurons, suggesting that there is a differential sensitivity to mutant huntingtin among different neuronal types.
APP transport is disrupted in striatal and hippocampal, but not cortical, neurons of homozygous Hdh150Q mice
Because overexpression of exogenous mutant huntingtin disrupts axonal transport by increasing the number of stationary particles in striatal neurons, we tested whether endogenous mutant huntingtin impairs axonal transport in cortical, striatal, or hippocampal neurons. To do this, APP-YFP movement was re- (Fig. 2D ) (Lin et al., 2001; Orr et al., 2008) . In addition, we found that there is no significant difference in the level of motor proteins, such as p150Glued, DHC, and KHC, between wildtype and mutant mouse brains (Fig. 2D) . A total of 197 APP-YFP particles from 12 wild-type cortical neurons and 175 AP-P-YFP particles from 18 Hdh150Q/150Q cortical neurons were analyzed. Similar to the observation in cortical neurons expressing exogenous mutant huntingtin, there is no difference in the average velocity of APP-YFP movement between cells from wild-type and mutant cortical neurons (anterograde: 0.57 vs 0.58 m/s, p Ͼ 0.05; retrograde: 0.39 vs 0.40 m/s, p Ͼ 0.05) (Fig. 5A) . In addition, endogenous mutant huntingtin does not change the number of stationary APP-YFP particles in primary cortical neurons (Fig. 5B) .
In striatal neurons, a total of 330 APP-YFP particles from 7 wild-type striatal neurons and 232 APP-YFP particles from 10 Hdh150Q/150Q striatal neurons were recorded and analyzed. Surprisingly, endogenous mutant huntingtin reduces the velocity of both anterograde and retrograde APP-YFP movement in striatal neurons (anterograde: 1.12 vs 0.56 m/s, p Ͻ 0.0001; retrograde: 0.89 vs 0.50 m/s, p ϭ 0.0016) (Fig. 5C ). Similar to the observation in striatal neurons expressing exogenous mutant huntingtin, endogenous mutant huntingtin also increases the number of stationary APP-YFP particles in primary striatal neurons (Fig. 5D) .
In hippocampal neurons, a total of 128 APP-YFP particles from 19 wild-type hippocampal neurons and 207 APP-YFP particles from 19 Hdh150Q/150Q hippocampal neurons were sampled. Similar to observations in striatal neurons, endogenous mutant huntingtin reduces the velocity of both anterograde (1.09 vs 0.48 m/s; p ϭ 0.0006) and retrograde (0.79 vs 0.36 m/s; p ϭ 0.0064) movement of APP-YFP (Fig. 5E ). As shown in Figure 5F , we found that the number of stationary APP-YFP particles in hippocampal neurons isolated from Hdh150Q/150Q mice increased, apparently at the expense of anterograde particles.
Thus, similar to the results with overexpression of mutant huntingtin, axonal transport of APP-YFP is impaired in striatal and hippocampal, but not cortical, neurons of homozygous Hdh150Q mice, indicating a differential sensitivity to mutant huntingtin between different neuronal types.
BDNF transport is disrupted in striatal but not cortical neurons of homozygous Hdh150Q mice HD patients experience preferential neuronal loss in the striatum. Survival of striatal neurons requires the growth factor BDNF that is made in the cortex and then transported to the striatum. Because endogenous mutant huntingtin disrupts axonal transport of APP-YFP in striatal but not cortical neurons, we asked whether endogenous mutant huntingtin impairs axonal transport of transfected BDNF in primary cortical and striatal neurons.
To monitor the effect of endogenous mutant huntingtin on transport of BDNF, primary mouse cortical neurons isolated from either wild-type or homozygous Hdh150Q knock-in mice were transfected with plasmid DNA encoding a rat BDNFmCherry protein. A total of 245 rat BDNF-mCherry particles from 11 wild-type cells and 355 rat BDNF-mCherry particles from 16 Hdh150Q/150Q cells were studied. Rat BDNF-mCherry moves at speeds of 1.23 and 0.72 m/s in anterograde and retrograde directions, respectively. There is no significant difference in the velocity of rat BDNF-mCherry movement in cortical neurons from wild-type or mutant neurons (Fig. 6 A) (anterograde movement: 1.23 vs 1.06 m/s, p Ͼ 0.05; retrograde movement: 0.72 vs 0.72 m/s, p Ͼ 0.05). In addition, there is no difference in the distribution of moving particles of rat BDNF-mCherry between cortical neurons from wild-type and mutant cells (Fig. 6 B) .
In striatal neurons, a total of 216 BDNF-mCherry particles from 12 wild-type striatal neurons and 268 BDNF-mCherry particles from 13 Hdh150Q/150Q striatal neurons were evaluated. Endogenous mutant huntingtin reduces the velocity of retrograde but not anterograde BDNF-mCherry movement in striatal neurons (Fig. 6C) (retrograde: 0.86 vs 0.56 m/s, p ϭ 0.03; anterograde: 0.74 vs 0.64 m/s, p Ͼ 0.05). Endogenous mutant huntingtin also increases the number of stationary BDNFmCherry particles in primary striatal neurons (Fig. 6 D) . Thus, retrograde transport of BDNF is impaired in striatal but not cortical neurons of homozygous Hdh150Q knock-in mice.
Biochemical behavior of huntingtin, kinesin-I, HAP1, and dynactin complexes are not altered in HD model mice Both loss and mutation of huntingtin result in fast axonal transport defects. Because huntingtin was reported to interact with both the anterograde and retrograde transport machinery, we examined the previously reported associations of huntingtin, HAP1, and motor protein complexes by sucrose gradient fractionation (Li et al., 1998; LaMonte et al., 2002; Gauthier et al., 2004) . To do this, total mouse forebrain extracts were fractionated by 5-20% sucrose gradients. As expected, dynein (DHC) and dynactin (p150Glued and p50) migrate as large complexes of 17-19S close to the bottom of the gradient (Fig.  7A, left) . Consistent with the finding that HAP1 interacts with p150Glued, HAP1 also migrates to the bottom of the gradient with a pattern similar to that of the dynein and dynactin complexes. In contrast, KHC is found in a smaller complex of ϳ8 -10S (fractions 5-7). The majority of huntingtin migrates between the kinesin and dynein/dynactin complexes with a size of about 15S. Only a small fraction of huntingtin comigrates with the KHC, dynein, or dynactin complexes.
We then tested whether the proposed associations of huntingtin with kinesin-I, dynein, and dynactin complexes are altered in HD model mice. Total forebrain extracts of 8-month-old homozygous Hdh150Q knock-in mouse were subjected to fractionation on 5-20% sucrose gradients. There is no gross change in the pattern of the dynein and dynactin complexes in the Hdh150Q/150Q knock-in mice compared with littermate control mice (Fig. 7A, right) . In addition, we found no change in the pattern of kinesin or HAP1 between mutant and control mice.
We also asked whether loss of huntingtin affects the interactions of huntingtin with kinesin and dynein/dynactin complexes. Total forebrain extracts of 6-month-old huntingtin conditional knock-out mice, in which the endogenous Hdh gene is removed by cre expressed from the synapsin promoter, were subjected to 5-20% sucrose gradient fractionation. We found no gross change in the pattern of the dynein and dynactin complexes in the brain extracts of huntingtin conditional knock-out mice compared with littermate control mice (Fig. 7B , right, Hdh floxed, syn-cre). Thus, the biochemical behaviors of huntingtin, kinesin-I, and dynein/dynactin complexes are not obviously altered by either reduction or mutation of huntingtin.
Discussion
Here we have examined the effects of loss of huntingtin and overexpression of both wild-type and mutant huntingtin on axonal transport in different neuronal types, including cortical, striatal, and hippocampal neurons. Summarized in Table 1 , these data show that depletion of endogenous huntingtin disrupts both anterograde and retrograde APP axonal transport. In addition, overexpression of wild-type huntingtin increases velocity of APP movements in all three types of neurons tested, whereas overexpression of mutant huntingtin disrupts APP transport in striatal and hippocampal, but not cortical, neurons. Moreover, axonal transport of BDNF is disrupted in striatal but not cortical neurons of homozygous Hdh150Q knock-in mice (Table 2) . Finally, although huntingtin is reported to interact with components of both anterograde and retrograde motors, neither reduction nor mutation of endogenous huntingtin appears to disrupt the kinesin-1, dynein, or dynactin complexes. Depletion of endogenous huntingtin disrupts axonal transport of APP in primary cortical neurons (Fig. 1) . Together with previous findings in Drosophila and mouse neurons (Gunawardena et al., 2003; Gauthier et al., 2004; Trushina et al., 2004) , these data establish that endogenous huntingtin is required for axonal transport of a variety of cargoes including APP, BDNF, and mitochondria in various types of neurons. However, the exact role of huntingtin in axonal transport remains unclear. Although huntingtin interacts with dynein intermediate chain, p150Glued, and kinesin light chain, loss of huntingtin does not affect either the level of or complexes of huntingtin, HAP1, dynactin, and kinesin-I (Figs. 2, 7A) . Thus, dysfunction of axonal transport in the absence of huntingtin is not attributable to a disruption of motor protein complexes, but instead may result from altered regulation of intact complexes. Moreover, in contrast to published data (Gauthier et al., 2004) , no changes in the biochemical behavior and potential interactions of huntingtin with HAP1 and motor protein complexes were observed in Hdh150Q/ 150Q brain extracts (Fig. 7A) . To test whether this discrepancy is caused by differences in the HD model mice used (Hdh150Q/150Q vs Hdh109Q/109Q), age differences, or methods, we performed sucrose gradient fractionation of brain extracts of 14-month-old Hdh109Q/109Q using a 7.5-25% sucrose gradient as described previously (Gauthier et al., 2004) . Again, we did not observe any change in the pattern of the kinesin-I, dynein, and dynactin complexes (data not shown). Although endogenous huntingtin is required for axonal transport of various cargoes, it is unclear whether mutant huntingtin disrupts all axonal transport. Mutant huntingtin was reported to impair movement of BDNF but not mitochondria in a cell line derived from the striatum of Hdh109Q/109Q knock-in mice (Gauthier et al., 2004) . However, mutant huntingtin disrupts transport of mitochondria and unknown vesicles in striatal and cortical neurons (Trushina et al., 2004; Chang et al., 2006; Orr et al., 2008) . Our data in striatal and hippocampal neurons supports the idea that mutant huntingtin disrupts axonal transport of various cargoes including BDNF, APP, and mitochondria. Why only BDNF transport but not mitochondria was altered in some previous experiments is unclear, but we suggest that the immortalized cell line derived from Hdh109Q/109Q mice may have properties different from unaltered striatal neurons.
The mechanism by which mutant huntingtin disrupts axonal transport remains elusive. Mutant huntingtin might form aggregates such that mutant huntingtin binds to cargoes and impairs their movement or physically blocks movement in axons (Chang et al., 2006; Orr et al., 2008) . However, this is unlikely in our 
experiments because no aggregates were observed in the presymptomatic primary neurons used (Lin et al., 2001) . Formation of huntingtin aggregates might precipitate motor proteins, thus reducing the soluble pool of motor proteins required for transport, as observed in both HD brain and Drosophila embryos (Gunawardena et al., 2003; Trushina et al., 2004) . However, no significant difference in the levels of soluble kinesin-I and dynein were found in brains of HD model mice (Fig. 2 D) (Orr et al., 2008) ). Because HD is a hereditary dominant disease, a great deal of effort has focused on gain-of-function phenotypes caused by mutant huntingtin. However, although the cellular functions of wild-type huntingtin are still not clear, it has been suggested that loss of wild-type huntingtin function also contributes to HD pathogenesis Gauthier et al., 2004) . Our findings that huntingtin is required for axonal transport and that mutant huntingtin lacks the ability of wild-type huntingtin to accelerate axonal transport suggest that loss of wild-type huntingtin function in fast axonal transport plays an important role in the development of HD. Overexpression of wild-type huntingtin also protects cells from excitotoxicity and apoptosis (Rigamonti et al., 2000; Ho et al., 2001; Leavitt et al., 2001 Leavitt et al., , 2006 Rigamonti et al., 2001) . We suggest that enhanced axonal transport and thus enhanced supply of some materials to synapses might also aid in neuroprotection.
Patients with HD suffer from motor dysfunction and exhibit preferential neuronal loss in the striatum. In striatal neurons, considerable evidence suggests that transport of various cargoes, such as BDNF, APP, and mitochondria, is disrupted (Fig. 4) (Trushina et al., 2004; Orr et al., 2008) . These data indicate that transport defects in presymptomatic neurons may be an important contributor to selective neurodegeneration. Disruption of transport could cause mislocalization of mitochondria, leading to apoptosis. Alternatively, defective transport could deplete proteins required for synaptic functions and for their survival, such as BDNF.
Striatal MSNs receive synaptic input and BDNF from the cortex via the corticostriatal pathway (Altar et al., 1997) . In addition to the cortex, striatal MSNs also receive BDNF from the substantia nigra, another region that expresses BDNF (Mufson et al., 1994 (Mufson et al., , 1999 Rite et al., 2003) . Intriguingly, we found that axonal transport of either APP or BDNF is not affected by mutation of huntingtin in primary mouse cortical neurons (Figs. 4 -6 , Table  2 ). Moreover, APP transport is not affected in primary cortical neurons from homozygous Hdh109Q mice either (data not shown). Together with previous data (Gauthier et al., 2004; Chang et al., 2006) , these data indicate that axonal transport in cortical neurons is more resistant to polyQ mutation of huntingtin. In contrast, mutant huntingtin affects axonal transport of APP and retrograde transport of BDNF in primary striatal neurons (Figs. 4 -6) . Thus, we suggest that selective loss of MSN is not attributable to a lack of anterograde BDNF transport in cortical neurons. Instead, our observations raise the possibility that global transport defects, especially reduced retrograde transport of endocytosed BDNF secreted by substantia nigra neurons, might lead to MSN degeneration in HD. Additional experiments are required to examine whether the secretion of BDNF by cortical neurons and uptake of secreted BDNF by striatal neurons are altered by mutation of huntingtin. In addition, it will be crucial to examine the transport of endocytosed BDNF in striatal neurons from HD model mice. BDNF-mCherry, Cells transfected with plasmid encoding rat BDNF tagged with mCherry fluorescent protein; Hdh150Q/150Q, primary neurons isolated from Hdh150Q/150Q neonates; A, anterograde transport; R, retrograde transport; V, velocity; P, number of moving vesicles (decreases in P translate to increased numbers of stalled or nonmoving vesicles, in principle lower processivity); 2, reduced; 7, no change. Note that all experiments are compared with transfections in wild-type cortical and striatal primary cultures.
